Instituto Nacional de Cancerología E.S.E (Site 1094)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Endometrial cancer

Running trials

• Active, not recruiting

  Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

  NCT04634877· Phase 3· Merck Sharp & Dohme LLC· Source